- ¥60bn
- ¥48bn
- ¥54bn
- 92
- 73
- 86
- 98
Annual balance sheet for Anest Iwata, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 13,200 | 14,320 | 14,512 | 16,931 | 21,336 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 6,399 | 7,742 | 8,724 | 9,427 | 9,877 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 28,893 | 34,326 | 36,773 | 40,571 | 45,229 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 11,355 | 11,449 | 12,461 | 13,715 | 15,095 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 49,459 | 55,819 | 60,137 | 66,144 | 69,202 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 9,607 | 11,616 | 11,720 | 12,789 | 12,161 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 17,216 | 20,195 | 20,111 | 21,985 | 22,348 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 32,243 | 35,623 | 40,026 | 44,159 | 46,854 |
| Total Liabilities & Shareholders' Equity | 49,459 | 55,819 | 60,137 | 66,144 | 69,202 |
| Total Common Shares Outstanding |